期刊文献+

糖基化终末代谢产物及其受体与动脉粥样硬化的关系及抑制剂的研究进展 被引量:4

下载PDF
导出
摘要 随着人类社会文明的发展,随之而来的各种慢性疾病成为了困扰世界各国的公共健康问题,尤其糖尿病的患病率呈逐年增加趋势。糖尿病的各种大血管和微血管病变成为患者致残率和致死率增加的重要原因,这是因为糖尿病患者的持续高血糖状态导致晚期糖基化终末产物(advanced glycation end products,AGEs)明显增加,该产物与糖基化终末产物受体(receptor of advanced glycation end products,RAGE)相结合导致的一系列的病理生物学效应明显加速了动脉粥样硬化的发展。
出处 《临床和实验医学杂志》 2016年第6期610-613,共4页 Journal of Clinical and Experimental Medicine
基金 北京市自然科学基金资助项目(编号:7122053)
  • 相关文献

参考文献3

二级参考文献189

  • 1Li Lin.RAGE on the Toll Road?[J].Cellular & Molecular Immunology,2006,3(5):351-358. 被引量:12
  • 2Basra, G., 2008. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis, 196(1):9-21. [doi:10.1016/ j. atherosclorosis.2007.07.025].
  • 3Bohlender, J.M., Franke, S., Stein, G., Wolf, G., 2005. Ad- vanced glycation end products and the kidney. Am. J. Physiol. Renal. PhysioL, 289(4):F645-F659. [doi:10. 1152/ajpronal.00398.2004].
  • 4Cohen, M.P., Ziyadeh, F.N., 1996. Role of Amadori-modified nonenzymatically glycated serum proteins in the patho- genesis of diabetic nephropathy.J. Am. Soc. Nephrol., 7(2):183-190.
  • 5Cohen, M.P., Ziyadeh, F.N., Chen, S., 2006. Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J. Lab. Clin. Med., 147(5):211-219. [doi:10.1016/j.lab.2005. 12.006].
  • 6Cuccurullo, C., Iezzi, A., Fazia, M.L., de Cesare, D., di Fran- cesco, A., Muraro, R., Bei, R., Ucchino, S., Spigonardo, F., Chiarelli, F., et al., 2006. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler. Thromb. Vasc. BioL, 26(12) 2716-2723. [doi:10.1161/01.ATV.0000249630.02085.12].
  • 7Devangelio, E., Santilli, F., Formoso, G., Ferroni, P., Bucci- arelli, L., Michetti, N., Clissa, C., Ciabattoni, G., Consoli, A., Davi, G., 2007. Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic. BioL Med., 43(4):511-518. [doi:10.1016/j.freoradbiomod.2007.03.015].
  • 8Flyvbjerg, A., Denner, L., Schrijvers, B.F., Tilton, R.G., Mo- gensen, T.H., Paludan, S.R., Rasch, R., 2004. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes, 53(1):166-172. [doi:10. 23371diabotos.53.1.166].
  • 9Forbes, J.M., Thorpe, S.R., Thallas-Bonke, V., Pete, J., Tho- mas, M.C., Deemer, E.R., Bassal, S., E1-Osta, A., Long, D.M., Panagiotopoulos, S., et al., 2005. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J. Am. Soc. Nephrol., 16(8):2363-2372. [doi:10.1681/ASN.2005010062].
  • 10Fried, L.F., Orchard, T.J., Kasiske, B.L., 2001. Effect of lipid reduction on the progression of renal disease: a meta- analysis. Kidney Int., 59(1):260-269. [doi:10.1046/].1523- 1755.2001.00487.x].

共引文献84

同被引文献24

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部